| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |